Press release
Probiotic IBS Supplements Market is expected to reach US$ 48.79 million by 2031 | The Good Bug, Unique Biotech Limited, Projoy Pvt Ltd, Nature's Bounty, Hyperbiotics.
Market Size and Growth:The Global Probiotic IBS Supplements Market size reached US$ 29.12 million in 2023 and is expected to reach US$ 48.79 million by 2031, growing with a CAGR of 7.65% during the forecast period 2024-2031.
The Probiotic IBS Supplements Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/probiotic-ibs-supplements-market?sz
The Probiotic IBS Supplements Market refers to the global industry focused on developing, manufacturing, and selling probiotic-based dietary supplements designed to manage symptoms of irritable bowel syndrome (IBS). These supplements target gut microbiota balance, digestive health, bloating, abdominal pain, and bowel irregularities, and are distributed through pharmacies, online platforms, and healthcare channels.
Recent Key Developments of United States:
✅ In December 2025, Biofermin Pharmaceutical introduced "Biofermin IBS" tablets as an OTC option for stress-induced diarrhea and constipation, capitalizing on established brand trust in Japan. (Note: page content lists this under Japan developments, aligning with last 3 months timeframe.)
✅ November 2025 saw Kobayashi Pharmaceutical launch a herbal-probiotic blend targeting "gas-type" IBS, addressing consumer concerns over bloating and social embarrassment through specialized formulation.
✅ In October 2025, Yakult Honsha published a clinical study demonstrating that L. casei Shirota improved IBS symptoms in Japanese patients with moderate severity, bolstering evidence for their products in clinical use.
Recent Key Developments of United States:
✅ August 2025: Nestlé Health Science acquired a U.S.-based probiotic startup focused on IBS supplements to bolster its gastrointestinal health offerings.
✅ May 2025: Procter & Gamble partnered with a biotech firm to develop advanced probiotic formulations tailored for IBS management.
✅ March 2025: Align Probiotics released an enhanced IBS-targeted formulation with improved gut microbiome support, supported by $15 million in funding.
List of the Key Players in the Probiotic IBS Supplements Market:
The Good Bug
Zeroharm Sciences Private Limited
Menoveda Life Sciences Private Limited
Unique Biotech Limited
Projoy Pvt Ltd
Pure NSM - Nutritional Supplement Manufacturers, Inc.
Nature's Bounty
Hyperbiotics
Advanced Vital Enzymes Private Ltd
Wren Laboratories Ltd
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/probiotic-ibs-supplements-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Probiotic IBS Supplements Market:
By Strain: Lactobacillus, Bifidobacterium, Other.
By Form: Tablet, Capsules, Liquid, Powder, Others.
By Distribution Channel: Supermarkets/Hypermarkets, Pharmacy/Health Stores, Online Stores, Other.
By End-User: Infants, Children, Adults, Seniors.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=probiotic-ibs-supplements-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Probiotic IBS Supplements market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Probiotic IBS Supplements Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Probiotic IBS Supplements market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Probiotic IBS Supplements Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Probiotic IBS Supplements Market in 2025?
◆ What is the projected growth rate of the Probiotic IBS Supplements Market through 2033?
◆ Who are the key players in the Probiotic IBS Supplements Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Probiotic IBS Supplements Market is expected to reach US$ 48.79 million by 2031 | The Good Bug, Unique Biotech Limited, Projoy Pvt Ltd, Nature's Bounty, Hyperbiotics. here
News-ID: 4329029 • Views: …
More Releases from DataM Intelligence 4Market Research
Biomedical Embedded Systems Market is expected to reach US$ 348.74 million by 20 …
Market Size and Growth:
The Global Biomedical Embedded Systems Market size reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.
The Biomedical Embedded Systems Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
Vitamins Market is expected to reach US$ 12.34 billion by 2032 | Major players - …
Market Size and Growth:
The Global Vitamins Market size reached US$ 7.12 billion in 2024 and is expected to reach US$ 12.34 billion by 2032, growing with a CAGR of 7.12% during the forecast period 2025-2032.
The Vitamins Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…
Savory Ingredients Market is expected to reach US$ 15.14 billion by 2032 | Major …
Market Size and Growth:
The Savory Ingredients Market size reached US$ 9.71 billion in 2024 and is expected to reach US$ 15.14 billion by 2032, growing with a CAGR of 5.71% during the forecast period 2025-2032.
The Savory Ingredients Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
Japan Digital Health Market is expected to reach US$ 51.42 Billion by 2033 | Top …
Market Size and Growth:
The Japan Digital Health Market size reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 Billion by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.
The Japan Digital Health Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
IBS Implant Market Research Report 2023 - Valuates reports
The global IBS Implant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Get Sample report - https://reports.valuates.com/request/sample/QYRE-Auto-35O11417/Global_IBS_Implant_Market_Research_Report_2022
North American market for IBS Implant is estimated to increase from $ million in 2023 to reach $ million by 2029, at…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…
